Chapter 11. Trastuzumab Deruxtecan Targeting HER2-expressing Cancers with a DXd-ADC System Consisting of a Novel Protease-sensitive Linker and DNA Topoisomerase I Inhibitor with a Hydroxyl Group
Drug DiscoveryChemical Linkers in Antibody-Drug Conjugates (ADCs)（2021）
关键词
dna topoisomerase,cancers,dxd-adc,protease-sensitive
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要